The Anatomic Pathology Imperative: Protect Revenue
With recent reimbursement and regulatory change, pathology groups are fighting for their existence. Massive cuts to 88305 tech component reimbursement, new reimbursement caps for certain biopsies, MIPS and MACRA program fallout, and the controversial handling and pricing of molecular pathology (MoPath) CPT codes all add up to an environment of unprecedented revenue compression, increased government scrutiny and complex reimbursement requirements.
At the same time, pathologists are fighting to establish a stronger voice in the shifting healthcare paradigm. Incorporating digital pathology, improving collaboration with physicians, and leveraging the rich diagnostic information generated by pathology systems, are all critical to surviving in the months and years to come.
In this environment, pathology labs need a technology infrastructure that supports optimized business processes and delivers the financial and operational integrity essential to laboratory success.
XIFIN anatomic pathology lab solutions are built on the cloud-based XIFIN Health Economics Optimization Platform, leveraging the platform's security, interoperability, advanced automated workflow, and connectivity to transform anatomic pathology for the new economic paradigm. XIFIN anatomic pathology lab solutions are built on the cloud-based XIFIN Health Economics Optimization Platform, leveraging the platform's security, interoperability, advanced automated workflow, and connectivity to transform anatomic pathology for the new economic paradigm.
XIFIN Anatomic Pathology Lab Solutions
A Technological Foundation for Health Economics Optimization
XIFIN Health Economics Optimization
The XIFIN Health Economics Optimization (HEO) platform gives diagnostic service providers the ability to leverage multiple information systems and data sources to maximize the effectiveness of both clinical and business decisions. Web-native, the XIFIN HEO platform links the many different stakeholders in the delivery of healthcare, optimizing both business and patient outcomes.Learn More
The XIFIN Advantage
Pathology Drives Cancer Moonshot Initiative- It All Begins with a Diagnosis
Since the Moonshot hit Congress, how can pathologists and other clinicians play a more significant role in the war on cancer? Changes in the way healthcare is delivered are driving the industry aggressively toward more cost-effective, value-based care models. Technology that enables the delivery of medicine in this new paradigm connects healthcare stakeholders with the tools they need to ensure patients get the best care at the lowest cost. Healthcare organizations are leveraging technology to improve patient care first and foremost, and to reduce cost by increasing efficiencies—all while ensuring appropriate reimbursement. Listen to the on-demand, recorded webinar to understand how technology can help us all reach the ultimate goal of empowering physicians through knowledge sharing to drive quality and demonstrate value for their practices.
Dr. Keith Kaplan
Clinical & Anatomical Pathologist
Dr. David Frishberg
Vice Chair, Anatomic Pathology
Cedars-Sinai Medical Center